Aspirin Market expected to reach USD 2.858 billion by 2030

Aspirin Market Trends & Forecast

According to a research study published by Knowledge Sourcing Intelligence (KSI), the aspirin market will expand from USD 2.507 billion in 2025 to USD 2.858 billion in 2030 at a CAGR of 2.81% during the forecast period.

The market is witnessing growth due to a rise in the incidence of cardiovascular diseases globally, which leads to increased demand for aspirins as they are highly prescribed for their anti-platelet properties, which work in preventing patients from heart strokes and attacks. Besides this, the growing aging population is also contributing to the rise in chronic diseases as older people are more susceptible to these diseases, which leads to the requirement of aspirin for the long term. Moreover, they are highly utilized for other purposes like in pain management due to its properties being an anti-inflammatory and analgesic agent, which diversify its role. Furthermore, the growing research and development by global pharmaceutical companies for new aspirin formulations can provide enhanced patient adherence to treatment regimens along with diversifying its application beyond present use, including in dementia and cancer-related treatment procedures, which will contribute to its growth during the projected period. ? View a sample of the report or purchase the complete study at: Global Aspirin Market Report

Aspirin Market Report Highlights

• The Over-the-Counter (OTC) segment is estimated to attain greater market share by 2030 in the product segment. The segment is witnessing growth due to its wide application along with ease of availability and convenience. They have widespread use in applications like fewer reduction, pain relief and inflammation management, among others, making them a commonly found product in the household. This segment is also attributing growth due to its availability in retail and online pharmacies, which enhance its access, and with no requirement of a prescription for purchase, leading to it having a wider consumer reach globally.
• The cardiovascular disease segment is the dominating segment in the global aspirin market in the application segment. Among the aspects that drive this rapid growth is the increasing prevalence of cardiovascular diseases, which leads to the growing preventive use of aspirin for improving heart health. Moreover, the supportive healthcare guideline supports the low-dose aspirin recommendation for patients who are at high cardiovascular risk, which is contributing to its adoption in the coming years. Further, the growing geriatric population also contributes to the rise in cardiovascular disease and other heart-related diseases, which leads to increased requirement of medication like aspirin, which can reduce the risk of heart attack and strokes.
• The online channel segment is the fastest growing segment in the distribution channel of the aspirin market due to the growing adoption of e-commerce globally along with increasing consumer preference to shop online due to convenience and easy accessibility to wider products to select from, Online platform also provide with attractive discounts ans promotional offers which attract cost-sensitive customer leading to driving the growth of this segment. Moreover, low-dose aspirin is easily available for purchase as OTC medication for preventive healthcare also contributes to online channel segment expansion.

• North America held the largest global aspirin market share due to growing awareness of preventive care along with robust healthcare infrastructure in the region. Additionally, the region has a high prevalence of cardiovascular diseases, chronic pain, and arthritis, together with a growing aging population who are more susceptible to these healthcare conditions, which leads to increasing aspirin consumption as therapeutic and preventive medication.

Report Coverage:

Report Metric	Details
Global Aspirin Market Size in 2025	USD 2.507 billion
Global Aspirin Market Size in 2030	USD 2.858 billion
Growth Rate	CAGR of 2.81%
Drivers	Rising Prevalence of Cardiovascular Diseases Growing Geriatric Population
Restraints	Emergence of Alternative Medications Side Effects and Safety Concerns
Segmentation	Product Application Distribution Channel Geography
List of Major Companies in Global Aspirin Market	Bayer AG Hebei Jingye Chemical Co., Ltd. JQC (Huayin) Pharmaceutical Co., Ltd. Perrigo Company plc L.N.K. International Inc.

Aspirin Market Growth Drivers and Restraints

Growth Drivers:

• Rising Prevalence of Cardiovascular Diseases: the increasing incidence of cardiovascular diseases such as heart attack, heart failure, among others, is leading to demand for aspirin. Aspirin is useful for the management as well as prevention of these chronic conditions, which is fuelling the market demand.
• Growing Geriatric Population: the growing aging population across the globe is leading to increased susceptibility to diverse chronic diseases that will contribute to growth in demand for aspirin. Age-related conditions like arthritis and cardiovascular diseases are leading to growth in the trend for consumption of aspirin.

Restraints:

• Emergence of Alternative Medications: the growth in research and development related to targeted therapeutic medications and agents for diverse health conditions, like pain management, could reduce the reliance on aspirin.
• Side Effects and Safety Concerns: the side effects of aspirin consumption, mainly gastrointestinal bleeding and ulcers, could lead to alternative drug usage, restraining the market.

Aspirin Market Key Development

• Product Launch: In July 2025, Bayer Aspirin announced the launch of its Aspirina product for the usage in health and pain relief options in the United States
• Trial Completion: In May 2025, the MRC Clinical Trials Unit at UCL announced the completion of a trial of Add-Aspirin for the treatment of cancers like colorectal, breast, gastro-oesophageal, or prostate cancer.

Aspirin Market Segmentation

Knowledge Sourcing Intelligence has segmented the Global Aspirin Market based on the product, application, distribution channel, and region: Global Aspirin Market, By Product

• Prescription
• OTC

Global Aspirin Market, By Application

• Cardiovascular Disease
• Pain/Fever/Inflammation
• Others

Global Aspirin Market, By Distribution Channel

• Hospital and Retail Pharmacies
• Online Channels

Global Aspirin Market, By Region

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others
• South America
  • Brazil
  • Argentina
  • Others
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • Others

Aspirin Market Key Players

• Bayer AG
• Hebei Jingye Chemical Co., Ltd.
• JQC (Huayin) Pharmaceutical Co., Ltd.
• Perrigo Company plc
• L.N.K. International Inc.
• Thermo Fisher Scientefic
• Taj Pharmaceuticals Limited
• Advance Pharmaceutical Inc.
• Allegiant Health
• KEM Pharma LLC

About Knowledge Sourcing Intelligence (KSI)

Knowledge Sourcing Intelligence (KSI) is a market research and consulting firm headquartered in India. Backed by seasoned industry experts, we offer syndicated reports, customized research, and strategic consulting services. Our proprietary data analytics framework, combined with rigorous primary and secondary research, enables us to deliver high-quality insights that support informed decision-making. Our solutions empower businesses to gain a competitive edge in their markets. With deep expertise across ten key sectors, including ICT, Chemicals, Semiconductors, and Healthcare, we effectively address the diverse needs of our global clientele.